Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in COLL — Collegium Pharmaceutical, Inc

CIK 902219 Boston, MA
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,339,124
-$83,123 QoQ
Shares Held
92,241
-10.9% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 280 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 70% None 30%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. COLL ranks #16 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,379,025 $747,197,111
2 ZTS
Zoetis Inc.
 9,423,895 $677,201,094
3 TEVA
Teva Pharmaceutical Industries Ltd
 7,671,157 $259,898,795
4 ALKS
Alkermes plc.
 2,814,804 $147,495,727
5 LNTH
Lantheus Holdings, Inc.
 1,013,063 $112,389,207
6 ELAN
Elanco Animal Health Inc
 2,676,050 $65,857,589
7 HLN
Haleon plc
 3,273,583 $30,542,527
8 XERS
Xeris Biopharma Holdings, Inc.
 2,365,103 $18,731,613

All Filings in COLL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,339,124 92,241
2026-03-31 $3,422,247 103,485
2025-12-31 $5,342,971 115,399
2025-09-30 $4,303,136 122,982
2025-06-30 $2,925,831 98,946
2025-03-31 $2,503,966 83,885
2024-12-31 $2,538,131 88,591
2024-09-30 $4,429,688 114,640
2024-06-30 $3,150,962 97,856
2024-03-31 $3,499,312 90,142